Soleo Health Extending Specialty Infusion Leadership Position

Soleo Health is an innovative national provider of home and alternate-site specialty infusion providing care in managing complex disease states through comprehensive pharmacy, nursing, education, and therapy management programs. Soleo Health operates 20 locations throughout the U.S. with national nursing coverage and pharmacy licensure in 50 states.

Soleo Health is one of the fastest growing specialty infusion companies in the industry. Recent activities included:

• Soleo Health’s Phoenix, Arizona location earned Specialty Pharmacy Accreditation from
• Soleo Health was selected as a specialty pharmacy partner for ADUHELM^™ (aducanumab-avwa). ADUHELMrecently received accelerated approval from the FDA for the treatment of Alzheimer’s disease. Soleo Health will distribute ADUHELM directly to providers and prescribers for patient administration throughout the United States. 
• Soleo Health opened its Thyroid Eye Disease (TED) Therapeutic Care Management Center (TCMC), dedicated to caring for andtreating patients with thyroid eye disease, a rare ophthalmic, vision-threatening condition. Soleo Health patients receiving care through the TED TCMC are treated with TEPEZZA^® manufactured by Horizon Therapeutics, the first and only FDA-approved treatment for TED.
• Soleo Health was selected by Houston Methodist to provide monoclonal antibody therapy (mAb) to COVID-19 patients in their homes. The hospital system is among the nation’s largest providers of mAb therapy and has a partnership with the U.S. Department of Human Services, supported by KPMG LLP, to expand access to COVID-19 monoclonal antibody treatment to underserved and disadvantaged patients in the greater Houston area.

Takeaway: Soleo Health’s care model and related services add value for patients with complex conditions, including rare and ultra-rare diseases